Fisher s BioImage Buy Rounds Out New Cell and Pathway Apps Unit, Yields Reagents for Cellomics | GenomeWeb

Fisher Biosciences has acquired Danish biotechnology firm BioImage for an undisclosed amount, and will fold the new subsidiary into a recently created Cell and Pathway Applications business unit that also includes Fisher brands Cellomics and Pierce, Fisher said this week.

The acquisition supports Fisher's recently stated goal of building its consumables offerings in the molecular biology tools arena, and, more specifically, of surrounding its Cellomics high-content screening business with as diverse and complementary a reagent catalog as possible.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.